ArticleTranslational pediatrics2026
Admission SpO
Article in Translational pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Severe pneumonia remains a major cause of pediatric intensive care unit (PICU) admission and death, particularly in settings where access to vaccination, timely care, and reliable oxygen systems is uneven. Conventional prognostic assessment combines clinical severity, organ dysfunction, and laboratory biomarkers, but many components are intermittent or invasive. This study aimed to evaluate whether the admission peripheral oxygen saturation to fraction of inspired oxygen (SpO Methods: This multicenter retrospective cohort study included 218 children with severe pneumonia admitted to the PICUs of three teaching hospitals in China from December 2021 to November 2024. Admission clinical characteristics, respiratory support, oxygenation indices, and laboratory variables were extracted from electronic medical records. The primary outcome was in-hospital mortality. Associations with mortality were evaluated using group comparisons, correlation analysis, exploratory logistic regression, and receiver operating characteristic (ROC) analysis. Results: Sixty-one children died, giving an in-hospital mortality rate of 28.0%. Non-survivors had lower admission S/F and SpO Conclusions: The admission S/F ratio was inversely associated with in-hospital mortality in children with severe pneumonia requiring respiratory support. It may be used at PICU admission and after changes in oxygen therapy as a rapid adjunct to clinical assessment, severity scores, lactate, and organ dysfunction markers. Because discrimination was modest and respiratory-support modalities were heterogeneous, the S/F ratio should not be used alone or as a fixed treatment threshold without prospective validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.